Trade Summary

3 days ago, Birznieks Gunther, serving as SVP, Business Development at Vanda Pharmaceuticals Inc. (VNDA), sold 42,431 shares at $8.27 per share, for a total transaction value of $350,730.00. Following this transaction, Birznieks Gunther now holds 494,197 shares of VNDA.

This sale represents a 8.00% decrease in Birznieks Gunther's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, March 2, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, March 4, 2026, 2 days after the trade was made.

Vanda Pharmaceuticals Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.